Evaluating the use of a mobile device for detection of atrial fibrillation in primary care.

anticoagulants atrial fibrillation biomedical technology prevalence primary health care

Journal

The British journal of cardiology
ISSN: 1753-4313
Titre abrégé: Br J Cardiol
Pays: England
ID NLM: 9503762

Informations de publication

Date de publication:
2021
Historique:
entrez: 24 6 2022
pubmed: 27 1 2021
medline: 27 1 2021
Statut: epublish

Résumé

A trial fibrillation (AF) increases cardio-embolic stroke risk, yet AF diagnosis and subsequent prophylactic anticoagulant prescription rates are suboptimal globally. This project aimed to increase AF diagnosis and subsequent anticoagulation prescription rates in East Midlands Clinical Commissioning Groups (CCGs). This service improvement evaluation of the East Midlands AF Advance programme investigated the implementation of mobile AF detection devices (Kardia, AliveCor) into primary-care practices within East Midlands CCGs, along with audit tools and clinician upskilling workshops designed to increase AF diagnosis and anticoagulation prescription rates. AF prevalence and prescription data were collected quarterly from July to September (Q3) 2017/18 to April to June/July to September (Q2/3) 2018/19. AF prevalence increased from 1.9% (22,975 diagnoses) in Q3 2017/18 to 2.4% (24,246 diagnoses) in Q2 2018/19 (p=0.026), while the percentage of high-risk AF patients receiving anticoagulants increased from 80.5% in Q3 2017/18 to 86.9% in Q3 2018/19 (p=0.57), surpassing the Public Health England 2019 target of 85%. The East Midlands AF Advance programme increased AF diagnosis and anticoagulation rates, which is expected to be of significant clinical benefit. The mobile AF detection devices provide a more practical alternative to traditional 12-lead electrocardiograms (ECGs) and should be incorporated into routine clinical practice for opportunistic AF detection, in combination with medication reviews to increase anticoagulant prescription.

Identifiants

pubmed: 35747477
doi: 10.5837/bjc.2021.005
pii: bjc.2021.005
pmc: PMC8822516
doi:

Types de publication

Journal Article

Langues

eng

Pagination

5

Informations de copyright

Copyright © 2021 Medinews (Cardiology) Limited.

Déclaration de conflit d'intérêts

None declared.

Références

JAMA. 1994 Mar 16;271(11):840-4
pubmed: 8114238
J Int Med Res. 2009 Mar-Apr;37(2):464-71
pubmed: 19383241
J Cardiovasc Electrophysiol. 2015 May;26(5):520-6
pubmed: 25651872
Heart Rhythm. 2015 Mar;12(3):554-559
pubmed: 25460854
Circulation. 2017 Nov 7;136(19):1784-1794
pubmed: 28851729
Stroke. 1991 Aug;22(8):983-8
pubmed: 1866765
Arq Bras Cardiol. 2018 Jan;110(1):7-15
pubmed: 29412241
Stroke. 1996 Oct;27(10):1765-9
pubmed: 8841326
Lancet Neurol. 2015 Apr;14(4):377-87
pubmed: 25748102

Auteurs

Patrick J Highton (PJ)

Research Associate Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW.

Amit Mistri (A)

Consultant in Stroke Medicine University Hospitals of Leicester NHS Trust, Leicester Royal Infirmary, Leicester, LE1 5WW.

Andre Ng (A)

Professor of Cardiac Electrophysiology Department of Cardiovascular Sciences, University of Leicester, Glenfield General Hospital, Leicester, LE3 9QP.

Karen Glover (K)

Director of Partner Relations and Operations Applied Research Collaboration East Midlands East Midlands Academic Health Science Network (EMAHSN), University of Nottingham Innovation Park, Nottingham, NG7 2TU.

Kamlesh Khunti (K)

Professor of Primary Care Diabetes and Vascular Medicine Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW.

Samuel Seidu (S)

NIHR Clinical Lecturer Diabetes Research Centre, University of Leicester, Leicester General Hospital, Leicester, LE5 4PW.

Classifications MeSH